Denali Therapeutics Funding & Investors
South San Francisco, CA
Denali Therapeutics Inc. operates as a biotechnology company. The Company discovers and develops medicines for neurodegenerative diseases. Denali Therapeutics serves patients in the State of California.
denalitherapeutics.comTotal Amount Raised: $345,423,008
Denali Therapeutics Funding Rounds
Post Ipo Equity
$93,600,000
Post Ipo Equity
$116,900,000
Series D
$70,000,000
Series D Investors
Casdin CapitalCormorant Asset ManagementPerceptive AdvisorsRedmile GroupVenrockWellington ManagementTekla Capital ManagementDeerfield ManagementSeries C
$20,000,000
Series C Investors
Pfizer Venture InvestmentsThird Rock VenturesCanaan PartnersRoche Venture FundSeries C
$20,000,000
Series C Investors
Pfizer Venture InvestmentsThird Rock VenturesCanaan PartnersRoche Venture FundIPO
Unknown
Series B
$1,423,000
Series B
$11,000,000
Series B Investors
Canaan PartnersThird Rock VenturesSeries B
$11,000,000
Series B Investors
Canaan PartnersThird Rock VenturesSeries B
$30,000,000
Series B Investors
Third Rock VenturesRoche Venture FundSeries B
$30,000,000
Series B Investors
Third Rock VenturesRoche Venture FundConvertible Note
$2,500,000
Convertible Note Investors
Mike PanesisConvertible Note
$2,500,000
Convertible Note Investors
Mike Panesis
Funding info provided by Diffbot.